{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:58:08Z","timestamp":1793235488223,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.medj.2024.05.017","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T10:34:34Z","timestamp":1719225274000},"page":"1096-1111.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients"],"prefix":"10.1016","volume":"5","author":[{"given":"Mireia","family":"Bernab\u00e9u-Gimeno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4963-7947","authenticated-orcid":false,"given":"Marco","family":"Pardo-Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gil-Brusola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"P\u00e9rez-Tarazona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Carrasco-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Quintana-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2829-8809","authenticated-orcid":false,"given":"Pilar","family":"Domingo-Calap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2024.05.017_bib1","series-title":"Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis","year":"2017"},{"key":"10.1016\/j.medj.2024.05.017_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3389\/fmicb.2017.00981","article-title":"Editorial: Phage therapy: Past, present and future","volume":"8","author":"Abedon","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.medj.2024.05.017_bib3","doi-asserted-by":"crossref","first-page":"S384","DOI":"10.1093\/cid\/ciad497","article-title":"Therapeutic phage monitoring: A review","volume":"77","author":"Bosco","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medj.2024.05.017_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/v10040188","article-title":"Characterizing phage genomes for therapeutic applications","volume":"10","author":"Philipson","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.medj.2024.05.017_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuab048","article-title":"Mechanisms and clinical importance of bacteriophage resistance","volume":"46","author":"Egido","year":"2022","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.medj.2024.05.017_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.micpath.2016.08.001","article-title":"In\u00a0vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB\/c mice","volume":"99","author":"Chadha","year":"2016","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.medj.2024.05.017_bib7","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/microorganisms10071324","article-title":"Phage products for fighting antimicrobial resistance","volume":"10","author":"Huang","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.medj.2024.05.017_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep26717","article-title":"Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa","volume":"6","author":"Chan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.medj.2024.05.017_bib9","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.tim.2023.04.008","article-title":"Immunogenicity of bacteriophages","volume":"31","author":"Champagne-Jorgensen","year":"2023","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.medj.2024.05.017_bib10","article-title":"Retrospective, observational analysis of the first one hundred consecutive cases of personalized bacteriophage therapy of difficult-to-treat infections facilitated by a Belgian consortium","author":"Pirnay","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.medj.2024.05.017_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cid\/ciac453","article-title":"Phage therapy of Mycobacterium infections: Compassionate use of phages in 20 patients with drug-resistant mycobacterial disease","volume":"76","author":"Dedrick","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medj.2024.05.017_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4161\/bact.1.1.14942","article-title":"Phages in nature","volume":"1","author":"Clokie","year":"2011","journal-title":"Bacteriophage"},{"key":"10.1016\/j.medj.2024.05.017_bib13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3389\/fmicb.2017.00566","article-title":"Phages in the human body","volume":"8","author":"Navarro","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.medj.2024.05.017_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/antibiotics12020217","article-title":"Antibiotic resistance in patients with cystic fibrosis: Past, present, and future","volume":"12","author":"Perikleous","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.medj.2024.05.017_bib15","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2024.05.017_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12890-016-0339-5","article-title":"Cystic fibrosis lung environment and Pseudomonas aeruginosa infection","volume":"16","author":"Bhagirath","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.medj.2024.05.017_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.addr.2014.11.017","article-title":"Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients","volume":"85","author":"Ciofu","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.medj.2024.05.017_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/CMR.00068-09","article-title":"The changing microbial epidemiology in cystic fibrosis","volume":"23","author":"LiPuma","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.medj.2024.05.017_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/microbiolspec.GPP3-0057-2018","article-title":"Antibiotic resistance and the MRSA problem","volume":"7","author":"Vestergaard","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.medj.2024.05.017_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.medj.2024.05.017_bib21","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1002\/ppul.25190","article-title":"Bacteriophage therapy for infections in CF","volume":"56","author":"Chan","year":"2021","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.medj.2024.05.017_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1751-7915.2011.00259.x","article-title":"Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens","volume":"4","author":"Kvachadze","year":"2011","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.medj.2024.05.017_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.medmal.2008.06.023","article-title":"Phage therapy experience at the Eliava Institute","volume":"38","author":"Kutateladze","year":"2008","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.medj.2024.05.017_bib24","article-title":"Bacteriophage therapy for pan-drug-resistant Pseudomonas aeruginosa in two persons with cystic fibrosis","volume":"11","author":"Hahn","year":"2023","journal-title":"J.\u00a0Investig. Med. High Impact Case Rep."},{"key":"10.1016\/j.medj.2024.05.017_bib25","article-title":"Personalized inhaled bacteriophage therapy decreases multidrug-resistant Pseudomonas aeruginosa header phage therapy reduces Pseudomonas bacterial load and virulence","author":"Chan","year":"2023","journal-title":"Medrxiv"},{"key":"10.1016\/j.medj.2024.05.017_bib26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/antibiotics11050616","article-title":"Salphage: Salvage bacteriophage therapy for recalcitrant MRSA prosthetic joint infection","volume":"11","author":"Doub","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.medj.2024.05.017_bib27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/microorganisms7100471","article-title":"Characterization of the three new kayviruses and their lytic activity against multidrug-resistant Staphylococcus aureus","volume":"7","author":"\u0141ubowska","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.medj.2024.05.017_bib28","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3390\/v14112339","article-title":"Isolation and characterization of lytic Pseudomonas aeruginosa bacteriophages isolated from sewage samples from Tunisia","volume":"14","author":"Akremi","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.medj.2024.05.017_bib29","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/v13050928","article-title":"Phage biocontrol of Pseudomonas aeruginosa in water","volume":"13","author":"Kauppinen","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.medj.2024.05.017_bib45","article-title":"gggenomes: A grammar of graphics for comparative genomics","author":"Hackl","year":"2023","journal-title":"R package version 0.9.12.9000"},{"key":"10.1016\/j.medj.2024.05.017_bib30","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0121-2022","article-title":"Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations","volume":"31","author":"Mitropoulou","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.medj.2024.05.017_bib31","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0154-2022","article-title":"Role of inhaled antibiotics in the era of highly effective CFTR modulators","volume":"32","author":"Elborn","year":"2023","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.medj.2024.05.017_bib32","first-page":"CD007639","article-title":"Nebuliser systems for drug delivery in cystic fibrosis","volume":"11","author":"Stanford","year":"2023","journal-title":"Cochrane Db Syst. Rev."},{"key":"10.1016\/j.medj.2024.05.017_bib33","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s11095-017-2213-4","article-title":"Anti-tuberculosis bacteriophage D29 delivery with a vibrating mesh nebulizer, jet nebulizer, and soft mist inhaler","volume":"34","author":"Carrigy","year":"2017","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.medj.2024.05.017_bib34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijpharm.2018.11.026","article-title":"Jet nebulization of bacteriophages with different tail morphologies\u00a0\u2013 Structural effects","volume":"554","author":"Leung","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.medj.2024.05.017_bib35","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1038\/s41467-023-39370-z","article-title":"Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa","volume":"14","author":"K\u00f6hler","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2024.05.017_bib36","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s41591-021-01403-9","article-title":"Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection","volume":"27","author":"Dedrick","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2024.05.017_bib37","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3389\/fmicb.2016.01681","article-title":"Antibody production in response to staphylococcal MS-1 phage cocktail in patients undergoing phage therapy","volume":"7","author":"Zaczek","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.medj.2024.05.017_bib38","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.cell.2022.04.024","article-title":"Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection","volume":"185","author":"Nick","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.medj.2024.05.017_bib39","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2024.05.017_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005595","article-title":"Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads","volume":"13","author":"Wick","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.medj.2024.05.017_bib41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic Local Alignment Search Tool","volume":"215","author":"Altschup","year":"1990","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.medj.2024.05.017_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112963","article-title":"Pilon: An integrated tool for comprehensive microbial variant detection and genome assembly improvement","volume":"9","author":"Walker","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.medj.2024.05.017_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btac776","article-title":"Pharokka: a fast scalable bacteriophage annotation tool","volume":"39","author":"Bouras","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.medj.2024.05.017_bib46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/v14020342","article-title":"PhageLeads: Rapid assessment of phage therapeutic suitability using an ensemble machine learning approach","volume":"14","author":"Yukgehnaish","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.medj.2024.05.017_bib44","article-title":"PHROG: Families of prokaryotic virus proteins clustered using remote homology","volume":"3","author":"Terzian","year":"2021","journal-title":"NAR Genom. Bioinform."},{"key":"10.1016\/j.medj.2024.05.017_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02960-22","article-title":"Comparative analysis of novel lytic phages for biological\u00a0control of phytopathogenic Xanthomonas spp","volume":"10","author":"Domingo-Calap","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.medj.2024.05.017_bib48","series-title":"Bacteriophages: Methods and Protocols","first-page":"141","year":"2009"},{"key":"10.1016\/j.medj.2024.05.017_bib49","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3390\/v15112211","article-title":"Human complement inhibits myophages againstPseudomonas aeruginosa","volume":"15","author":"Egido","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.medj.2024.05.017_bib50","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3390\/v13101898","article-title":"A case of in\u00a0situ phage\u00a0therapy against Staphylococcus aureus in a bone allograft polymicrobial\u00a0biofilm infection: Outcomes and phage-antibiotic interactions","volume":"13","author":"Van Nieuwenhuyse","year":"2021","journal-title":"Viruses"}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634024002216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634024002216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T19:31:43Z","timestamp":1759865503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634024002216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2666634024002216"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2024.05.017","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2024.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}